Filter Results:
(1,307)
Show Results For
- All HBS Web
(6,024)
- Faculty Publications (1,307)
Show Results For
- All HBS Web
(6,024)
- Faculty Publications (1,307)
Majority
→
- February 2007
- Module Note
A Man for All Seasons Summary: Reasoning from Multiple Moralities
By: Sandra J. Sucher
A summary of the major themes discussed in the eight class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "A Man for All Seasons Summary: Reasoning from Multiple Moralities." Harvard Business School Module Note 607-072, February 2007.
- February 2007
- Module Note
American Ground Summary: Assuming Leadership
By: Sandra J. Sucher
A summary of the major themes discussed in the thirteenth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "American Ground Summary: Assuming Leadership." Harvard Business School Module Note 607-077, February 2007.
- February 2007 (Revised March 2007)
- Module Note
Antigone: The Challenge of Right Versus Right
By: Sandra J. Sucher
A summary of the major themes discussed in the second class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Antigone: The Challenge of Right Versus Right." Harvard Business School Module Note 607-066, February 2007. (Revised March 2007.)
- February 2007 (Revised March 2007)
- Module Note
Blessed Assurance: The Challenge of a Moral Dilemma
By: Sandra J. Sucher
A summary of the major themes discussed in the third class of The Moral Leader (EC curriculum). View Details
Keywords: Moral Sensibility
Sucher, Sandra J. "Blessed Assurance: The Challenge of a Moral Dilemma." Harvard Business School Module Note 607-067, February 2007. (Revised March 2007.)
- February 2007
- Module Note
Endurance Summary: The Challenge of Right Versus Wrong
By: Sandra J. Sucher
A summary of the major themes discussed in the first class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Endurance Summary: The Challenge of Right Versus Wrong." Harvard Business School Module Note 607-065, February 2007.
- February 2007
- Module Note
Katharine Graham Summary: Taking a Stand
By: Sandra J. Sucher
A summary of the major themes discussed in the twelfth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Katharine Graham Summary: Taking a Stand." Harvard Business School Module Note 607-076, February 2007.
- February 2007
- Module Note
The Prince Summary: Exercising Authority
By: Sandra J. Sucher
A summary of the major themes discussed in the ninth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "The Prince Summary: Exercising Authority." Harvard Business School Module Note 607-073, February 2007.
- February 2007
- Module Note
The Remains of the Day Summary: Reasoning From a Moral Code
By: Sandra J. Sucher
A summary of the major themes discussed in the seventh class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "The Remains of the Day Summary: Reasoning From a Moral Code." Harvard Business School Module Note 607-071, February 2007.
- February 2007
- Module Note
The Secret Sharer Summary: Earning Legitimacy
By: Sandra J. Sucher
A summary of the major themes discussed in the tenth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "The Secret Sharer Summary: Earning Legitimacy." Harvard Business School Module Note 607-074, February 2007.
- February 2007 (Revised March 2007)
- Module Note
The Sweet Hereafter Summary: Reasoning from Personal Perspective
By: Sandra J. Sucher
A summary of the major themes discussed in the sixth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "The Sweet Hereafter Summary: Reasoning from Personal Perspective." Harvard Business School Module Note 607-070, February 2007. (Revised March 2007.)
- February 2007 (Revised March 2007)
- Module Note
Things Fall Apart Summary: The Challenge of New Principles
By: Sandra J. Sucher
A summary of the major themes discussed in the fourth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Things Fall Apart Summary: The Challenge of New Principles." Harvard Business School Module Note 607-068, February 2007. (Revised March 2007.)
- February 2007
- Module Note
Trifles Summary: Reasoning from Moral Theory
By: Sandra J. Sucher
A summary of the major themes discussed in the fifth class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Trifles Summary: Reasoning from Moral Theory." Harvard Business School Module Note 607-069, February 2007.
- February 2007 (Revised March 2007)
- Module Note
Truman and the Bomb Summary: Balancing Benefits and Harms
By: Sandra J. Sucher
A summary of the major themes discussed in the eleventh class of The Moral Leader (EC curriculum). View Details
Sucher, Sandra J. "Truman and the Bomb Summary: Balancing Benefits and Harms." Harvard Business School Module Note 607-075, February 2007. (Revised March 2007.)
- February 2007 (Revised March 2007)
- Case
UBS and Climate Change--Warming Up to Global Action?
By: Felix Oberholzer-Gee, Forest L. Reinhardt and Elizabeth Raabe
Marco Suter, Executive Vice-Chairman, UBS Board of Directors, carefully studied the chart on his desk. It showed the public commitment of major financial institutions to help mitigate global warming. Evidently, UBS lagged behind its competitors. The graph was part of a... View Details
Keywords: Climate Change; Energy Conservation; Cost vs Benefits; Law; Financial Institutions; Environmental Sustainability; Corporate Accountability; Financial Services Industry
Oberholzer-Gee, Felix, Forest L. Reinhardt, and Elizabeth Raabe. "UBS and Climate Change--Warming Up to Global Action?" Harvard Business School Case 707-511, February 2007. (Revised March 2007.)
- January 2007
- Background Note
Note on Biotech Business Development
By: Richard G. Hamermesh and Robert F. Higgins
Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious... View Details
Keywords: Agreements and Arrangements; Entrepreneurship; Intellectual Property; Biotechnology Industry
Hamermesh, Richard G., and Robert F. Higgins. "Note on Biotech Business Development." Harvard Business School Background Note 807-032, January 2007.
- December 2006 (Revised October 2007)
- Case
Embrapa
By: David E. Bell and Mary L. Shelman
Brazil's national agricultural research corporation, Embrapa, has developed an integrated crop and livestock production system that will allow farmers and ranchers to intensify production and improve profitability. Broad adoption of the technology would provide the... View Details
Keywords: Agribusiness; Policy; Business and Government Relations; Environmental Sustainability; Technology Adoption; Agriculture and Agribusiness Industry; Brazil
Bell, David E., and Mary L. Shelman. "Embrapa." Harvard Business School Case 507-019, December 2006. (Revised October 2007.)
- 2006
- Working Paper
Democratizing Entry: Banking Deregulations, Financing Constraints, and Entrepreneurship
By: William R. Kerr and Ramana Nanda
We examine entrepreneurship and creative destruction following US banking deregulations using Census Bureau data. US banking reforms brought about exceptional growth in both entrepreneurship and business closures. The vast majority of closures, however, were the new... View Details
Keywords: Business Exit or Shutdown; Market Entry and Exit; Capital Markets; Entrepreneurship; Outcome or Result; Business Startups; Banks and Banking; Banking Industry; United States
Kerr, William R., and Ramana Nanda. "Democratizing Entry: Banking Deregulations, Financing Constraints, and Entrepreneurship." Harvard Business School Working Paper, No. 07-033, December 2006. (Revised July 2007, December 2007, October 2008, December 2008.)
- December 2006 (Revised January 2007)
- Case
Infosys in India: Building a Software Giant in a Corrupt Environment
By: Rawi E. Abdelal, Rafael M. Di Tella and Prabakar (PK) Kothandaraman
Shortly after Infosys was founded in 1981, its managers faced a major turning point when they made a decision to operate without giving in to the petty corruption rife in the Indian economy. Within just a few years, that decision had truly defined the company. Over the... View Details
Keywords: History; Management Style; Moral Sensibility; Policy; Business and Government Relations; Decisions; Business Growth and Maturation; Situation or Environment; Crime and Corruption; Business Strategy; Information Technology Industry; Computer Industry; India
Abdelal, Rawi E., Rafael M. Di Tella, and Prabakar (PK) Kothandaraman. "Infosys in India: Building a Software Giant in a Corrupt Environment." Harvard Business School Case 707-030, December 2006. (Revised January 2007.)
- November 2006 (Revised May 2025)
- Case
Eli Lilly: Developing Cymbalta
By: Elie Ofek and Ron Laufer
Anticipating the expiration of its Prozac patent, Eli Lilly has to make tough decisions regarding the development of its next-generation antidepressant drug. In particular, the company needs to decide whether to first establish that once-a-day dosing for Cymbalta... View Details
Keywords: Decision Choices and Conditions; Marketing Strategy; Product Launch; Product Development; Research and Development; Pharmaceutical Industry
Ofek, Elie, and Ron Laufer. "Eli Lilly: Developing Cymbalta." Harvard Business School Case 507-044, November 2006. (Revised May 2025.)
- November 2006 (Revised November 2007)
- Case
Strategy in the Twenty First Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc.
By: David J. Collis and Troy Smith
The global pharmaceutical industry has gone through substantial changes in the last few decades and pharmaceutical firms face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic... View Details
Keywords: Mergers and Acquisitions; Growth and Development Strategy; Product Development; Research and Development; Corporate Strategy; Pharmaceutical Industry; United States
Collis, David J., and Troy Smith. "Strategy in the Twenty First Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc." Harvard Business School Case 707-509, November 2006. (Revised November 2007.)